Revenue from the global soft tissue repair market is anticipated to expand at a healthy CAGR during the forecast period.
On the basis of product type, the global soft tissue repair market is segmented into allograft, xenograft, alloplast, and synthetic. In terms of value, allograft segment is expected to account for ~43% share of the global soft tissue repair market by 2024 end. This segment is expected to maintain its dominance and emerge the most attractive segment during the forecast period.
Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/soft-tissue-repair-market.asp
On the basis of application, the global soft tissue repair market is segmented into breast reconstruction, hernia repair, vaginal sling, dental problems, dermatology, orthopedics, and others. Orthopedics segment is further sub-segmented into dural repair, sports medication and tendon reinforcement, and others. In terms of value, orthopedic segment is expected to account for ~20% share of the global soft tissue repair market by 2024 end. This segment is expected to maintain its dominance and emerge the most attractive segment during the forecast period.
On the basis of end user, the global soft tissue repair market is segmented into hospitals, ambulatory surgical centers, and clinics. Increasing hospitalization rate for orthopedic surgeries is expected to boost revenue growth of hospitals segment in the global soft tissue repair market.
Download Report Sample @ http://www.persistencemarketresearch.com/samples/4448
On the basis of region, the global soft tissue repair market is segmented into North America, Latin America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). In terms of value, North America accounted for over a third of the overall market revenue in 2015 and is estimated to continue to remain dominant by 2016 end. Europe and APAC are expected to register significant growth over the forecast period. Allografts segment accounts for a majority share in terms revenue of the global soft tissue repair market. Alloplasts are used for volume restoration and are usually preferred for applications in dermatology and breast reconstruction. Increasing incidence of trauma and burns are expected to fuel revenue growth of allografts and alloplast in the global soft tissue repair market in the near future.
Some of the key players identified in the global soft tissue repair drug market report include B. Braun Melsungen AG, Baxter, C. R. Bard, Inc., Johnson & Johnson Private Limited, Stryker, Medtronic, Acera Surgical, Inc., Anthrex, Inc., and Acelity L.P. Inc.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353